Human Galectin-1 Improves Sarcolemma Stability and Muscle Vascularization in the mdx Mouse Model of Duchenne Muscular Dystrophy

Duchenne muscular dystrophy (DMD) is a devastating disease caused by mutations in the dystrophin gene that result in the complete absence of dystrophin protein. We have shown previously that recombinant mouse Galectin-1 treatment improves physiological and histological outcome measures in the mdx mo...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Mol Ther Methods Clin Dev
Autors principals: Wuebbles, Ryan D., Cruz, Vivian, Van Ry, Pam, Barraza-Flores, Pamela, Brewer, Paul D., Jones, Peter, Burkin, Dean J.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Gene & Cell Therapy 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6369265/
https://ncbi.nlm.nih.gov/pubmed/30788383
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omtm.2019.01.004
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars